Close Menu

clinical trial

However, the company confirmed that it is no longer commercializing its test, the Enigma ML Influenza A/B detection assay, in partnership with GlaxoSmithKline as was previously reported.

Enigma's testing platform combines fully automated sample extraction with real-time PCR amplification and detection and is designed to achieve results in less than one hour.

The BATTLE trial was the first prospective, adaptively randomized study in pretreated non-small cell lung cancer patients that mandated tumor profiling with “real time” biopsies. The 255 patients in the trial were adaptively randomized to four arms — erlotinib, vandetanib, erlotinib plus bexarotene, or sorafenib — based on their biomarker profiles.

The deal will provide "biopharmaceutical firms with a better understanding of modes of action of a variety of therapeutics and the role of biomarkers in the oncology drug development process."

The firm expects to complete the clinical trials this summer and then submit an application with FDA.

In the first study, four AIDS patients with lymphoma received treatment and are doing well, with no signs of treatment-related adverse effects.

The move marks the company's foray into the ranks of clinical-stage drug developers and its first steps toward becoming a therapeutics marketer.

The firm's shares jumped in early trade after a study published online on the American Journal of Obstetrics and Gynecology website showed the firm's T21 test demonstrated 100 percent sensitivity and 99.7 percent specificity.

The new FDA rule will require consent forms for medical device and drug trials to explain that data will be made public through an NIH website.

NCI intends to consolidate the nine groups that currently conduct trials in adult cancer patients into four state-of-the-art entities that will design and perform improved clinical trials of cancer therapies.

Pages

The New York Times reports on an effort to address in high school biology classes misconceptions regarding race and genetics.

60 Minutes speaks with Harvard's George Church about tackling the effects of aging and more.

In PLOS this week: rare alterations in Timothy syndrome, analysis of twins' gut microbiomes, and more.

GenomeWeb reports that Veritas Genetics is suspending its US operations.